Artivion [AORT] vs Axogen [AXGN] Detailed Stock Comparison

Artivion Inc.

NYSE
Loading...

Axogen Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Artivion Inc. wins in 14 metrics, Axogen Inc. wins in 5 metrics, with 0 ties. Artivion Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Artivion Inc. Axogen Inc. Better
P/E Ratio (TTM) 179.71 -110.18 Artivion Inc.
Price-to-Book Ratio 4.03 13.15 Artivion Inc.
Debt-to-Equity Ratio 57.67 55.50 Axogen Inc.
PEG Ratio -1.59 0.04 Axogen Inc.
EV/EBITDA 36.67 -2,165.44 Artivion Inc.
Profit Margin (TTM) 2.21% -6.97% Artivion Inc.
Operating Margin (TTM) 8.09% -16.31% Artivion Inc.
EBITDA Margin (TTM) 8.09% N/A N/A
Return on Equity 2.70% -13.49% Artivion Inc.
Return on Assets (TTM) 2.34% -2.31% Artivion Inc.
Free Cash Flow (TTM) $839,000 $-4.78M Artivion Inc.
1-Year Return -28.85% 341.03% Axogen Inc.
Price-to-Sales Ratio (TTM) 4.15 8.27 Artivion Inc.
Enterprise Value $1.97B $1.89B Artivion Inc.
EV/Revenue Ratio 4.47 8.40 Artivion Inc.
Gross Profit Margin (TTM) 63.06% 74.13% Axogen Inc.
Revenue per Share (TTM) $10 $5 Artivion Inc.
Earnings per Share (Diluted) $0.21 $-0.34 Artivion Inc.
Beta (Stock Volatility) 1.62 0.98 Axogen Inc.
Short % of Float 4.13% 6.92% Artivion Inc.

Artivion Inc. vs Axogen Inc. Stock Performance Analysis

Loading Price Chart...

AORT
AXGN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Artivion Inc.4.83%3.33%-7.47%-43.66%-53.56%-52.61%
Axogen Inc.1.72%5.50%6.71%33.19%46.88%41.10%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Artivion Inc.-28.85%25.55%-29.37%70.34%288.03%318.75%
Axogen Inc.341.03%367.90%106.53%628.81%1,769.57%12,185.71%

Performance & Financial Health Analysis: Artivion Inc. vs Axogen Inc.

MetricAORTAXGN
Market Information
Market Cap i$1.83B$1.94B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i273,5521,245,238
90 Day Avg. Volume i406,5541,068,353
Last Close$21.07$43.74
52 Week Range$19.16 - $48.25$9.22 - $45.83
% from 52W High-56.33%-4.56%
All-Time High$48.25 (Dec 17, 2025)$56.85 (Jul 23, 2018)
% from All-Time High-56.33%-23.06%
Growth Metrics
Quarterly Revenue Growth0.19%0.21%
Quarterly Earnings Growth0.19%0.21%
Financial Health
Profit Margin (TTM) i0.02%-0.07%
Operating Margin (TTM) i0.08%-0.16%
Return on Equity (TTM) i0.03%-0.13%
Debt to Equity (MRQ) i57.6755.50
Cash & Liquidity
Book Value per Share (MRQ)$9.37$2.73
Cash per Share (MRQ)$1.36$0.80
Operating Cash Flow (TTM) i$39.88M$812,000
Levered Free Cash Flow (TTM) i$-20,097,624$3.58M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00$0.00

Valuation & Enterprise Metrics Analysis: Artivion Inc. vs Axogen Inc.

MetricAORT (Apr 26, 2026)AXGN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i179.71-110.18
Forward P/E i32.6547.31
PEG Ratio i-1.590.04
Price to Sales (TTM) i4.158.27
Price to Book (MRQ) i4.0313.15
Market Capitalization
Market Capitalization i$1.83B$1.94B
Enterprise Value i$1.97B$1.89B
Enterprise Value Metrics
Enterprise to Revenue i4.478.40
Enterprise to EBITDA i36.67-2,165.44
Risk & Other Metrics
Beta i1.620.98
Book Value per Share (MRQ) i$9.37$2.73

Financial Statements Comparison: Artivion Inc. vs Axogen Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAORT (2025)AXGN (2025)
Revenue/Sales i441.33M225.21M
Cost of Goods Sold i157.10M57.86M
COGS % of Revenue i35.6%25.7%
Gross Profit i284.23M167.35M
Gross Margin i64.4%74.3%
Research & Development i30.99M32.89M
Operating Income (EBIT) i26.75M-7.85M
Operating Margin i6.1%-3.5%
EBITDA i59.48M826,000
EBITDA Margin i13.5%0.4%
Pre-Tax Income i14.78M-15.70M
Pre-Tax Income % of Revenue i3.3%-7.0%
Income Tax i5.01MN/A
Income Tax % of Revenue i1.1%0.0%
Net Income (Profit) i9.77M-15.70M
Profit Margin i2.2%-7.0%

Balance Sheet & Liquidity Metrics

MetricAORT (2025)AXGN (2025)
Cash & Equivalents i64.91M35.55M
Total Current Assets i358.08M120.42M
Total Current Assets % of Revenue i81.1%53.5%
Total Current Liabilities i101.56M23.56M
Total Current Liabilities % of Revenue i23.0%10.5%
Long-Term Debt i252.24M65.26M
Long-Term Debt % of Revenue i57.2%29.0%
Total Shareholders Equity i448.23M128.85M
Retained Earnings i-51.50M-306.96M
Retained Earnings % of Revenue i-11.7%-136.3%
Property, Plant & Equipment i34.70M29.38M

Cash Flow Statement Comparison

MetricAORT (2025)AXGN (2025)
Operating Cash Flow i41.11M10.26M
Operating Cash Flow % of Revenue i9.3%4.6%
Capital Expenditures iN/A-3.75M
Free Cash Flow i839,000-4.78M
FCF Margin i0.2%-2.1%
Debt Repayment i-2.46M-32,000
Common Stock Repurchase i0N/A

Short Interest & Institutional Ownership Analysis

MetricAORTAXGN
Shares Short i1.67M3.50M
Short Ratio i4.284.04
Short % of Float i4.13%6.92%
Shares Outstanding i47.84M47.20M
Float Shares i45.40M50.75M
% Held by Insiders i4.52%2.12%
% Held by Institutions i91.48%88.11%
% Held by Public i4.00%9.77%

Dividend Analysis & Yield Comparison: Artivion Inc. vs Axogen Inc.

MetricAORTAXGN
Last 12-Month Dividend i$0.00$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00$0.00
Ex-Dividend DateN/AN/A